annual shareholders equity:
$309.85M+$63.94M(+26.00%)Summary
- As of today (August 22, 2025), ELVN annual stockholders equity is $309.85 million, with the most recent change of +$63.94 million (+26.00%) on December 31, 2024.
- During the last 3 years, ELVN annual shareholders equity has risen by +$202.98 million (+189.95%).
- ELVN annual shareholders equity is now at all-time high.
Performance
ELVN Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$488.47M+$200.18M(+69.43%)Summary
- As of today (August 22, 2025), ELVN quarterly stockholders equity is $488.47 million, with the most recent change of +$200.18 million (+69.43%) on June 30, 2025.
- Over the past year, ELVN quarterly shareholders equity has increased by +$183.54 million (+60.19%).
- ELVN quarterly shareholders equity is now at all-time high.
Performance
ELVN quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELVN Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.0% | +60.2% |
| 3 y3 years | +189.9% | +696.0% |
| 5 y5 years | +734.3% | +359.5% |
ELVN Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +243.8% | at high | +752.7% |
| 5 y | 5-year | at high | +734.3% | at high | +752.7% |
| alltime | all time | at high | +734.3% | at high | +752.7% |
ELVN Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $488.47M(+69.4%) |
| Mar 2025 | - | $288.30M(-7.0%) |
| Dec 2024 | $309.85M(+26.0%) | $309.85M(+7.4%) |
| Sep 2024 | - | $288.40M(-5.4%) |
| Jun 2024 | - | $304.93M(-4.0%) |
| Mar 2024 | - | $317.71M(+29.2%) |
| Dec 2023 | $245.91M(+172.8%) | $245.91M(-6.1%) |
| Sep 2023 | - | $261.75M(-6.2%) |
| Jun 2023 | - | $278.99M(-4.3%) |
| Mar 2023 | - | $291.42M(+223.3%) |
| Dec 2022 | $90.13M | $90.13M(+57.3%) |
| Sep 2022 | - | $57.29M(-6.6%) |
| Jun 2022 | - | $61.36M(-15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $72.41M(-15.8%) |
| Dec 2021 | $106.86M(+26.6%) | - |
| Dec 2021 | - | $86.03M(-13.4%) |
| Sep 2021 | - | $99.37M(+53.0%) |
| Jun 2021 | - | $64.97M(-14.1%) |
| Mar 2021 | - | $75.59M(-10.5%) |
| Dec 2020 | $84.44M(-272.9%) | $84.44M(-10.8%) |
| Sep 2020 | - | $94.70M(-10.9%) |
| Jun 2020 | - | $106.30M(+1.0%) |
| Mar 2020 | - | $105.19M |
| Dec 2019 | -$48.85M(+85.6%) | - |
| Dec 2018 | -$26.32M(+69.4%) | - |
| Dec 2017 | -$15.53M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Enliven Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of ELVN is $309.85M
What is the all time high annual shareholders equity for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual stockholders equity is $309.85M
What is Enliven Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, ELVN annual stockholders equity has changed by +$63.94M (+26.00%)
What is Enliven Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of ELVN is $488.47M
What is the all time high quarterly shareholders equity for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly stockholders equity is $488.47M
What is Enliven Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, ELVN quarterly stockholders equity has changed by +$183.54M (+60.19%)